BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 31932467)

  • 1. Impact of Genetics on Mature Lymphoid Leukemias and Lymphomas.
    Bailey NG; Elenitoba-Johnson KSJ
    Cold Spring Harb Perspect Med; 2020 Nov; 10(11):. PubMed ID: 31932467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LYmphoid NeXt-Generation Sequencing (LYNX) Panel: A Comprehensive Capture-Based Sequencing Tool for the Analysis of Prognostic and Predictive Markers in Lymphoid Malignancies.
    Navrkalova V; Plevova K; Hynst J; Pal K; Mareckova A; Reigl T; Jelinkova H; Vrzalova Z; Stranska K; Pavlova S; Panovska A; Janikova A; Doubek M; Kotaskova J; Pospisilova S
    J Mol Diagn; 2021 Aug; 23(8):959-974. PubMed ID: 34082072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of cytogenetics in neoplastic diseases.
    Sandberg AA
    Crit Rev Clin Lab Sci; 1985; 22(3):219-74. PubMed ID: 3899509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic aberrations in small B-cell lymphomas and leukemias: molecular pathology, clinical relevance and therapeutic targets.
    Bogusz AM; Bagg A
    Leuk Lymphoma; 2016 Sep; 57(9):1991-2013. PubMed ID: 27121112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A greater incidence of complex translocations in myeloid leukemias than in lymphomas and lymphoid leukemias associated with IGH rearrangement.
    Fitzgerald PH; Morris CM
    Cancer Genet Cytogenet; 1996 Jan; 86(1):8-12. PubMed ID: 8616794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relation of oncogenesis and cytogenetics in leukemia and lymphoma.
    Pearson M; Rowley JD
    Annu Rev Med; 1985; 36():471-83. PubMed ID: 3888062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetics of lymphomas.
    Campbell LJ
    Pathology; 2005 Dec; 37(6):493-507. PubMed ID: 16373229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. V(D)J-mediated translocations in lymphoid neoplasms: a functional assessment of genomic instability by cryptic sites.
    Marculescu R; Le T; Simon P; Jaeger U; Nadel B
    J Exp Med; 2002 Jan; 195(1):85-98. PubMed ID: 11781368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New developments in non-Hodgkin lymphoid malignancies.
    Ganapathi KA; Brown LE; Prakash S; Bhargava P
    Pathology; 2021 Apr; 53(3):349-366. PubMed ID: 33685720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular abnormalities in lymphomas].
    Delsol G
    Bull Cancer; 2010 Nov; 97(11):1347-64. PubMed ID: 21084243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytogenetic findings in 175 patients indicate that items of the Kiel classification should not be disregarded in the REAL classification of lymphoid neoplasms.
    Nowotny H; Karlic H; Grüner H; Hirsch J; Vesely M; Nader A; Heinz R
    Ann Hematol; 1996 May; 72(5):291-301. PubMed ID: 8645741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytogenetic abnormalities in reactive lymphoid hyperplasia: byproducts of the germinal centre reaction or indicators of lymphoma?
    Sevilla DW; Murty VV; Sun XL; Nandula SV; Mansukhani MM; Alobeid B; Bhagat G
    Hematol Oncol; 2011 Jun; 29(2):81-90. PubMed ID: 20687199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic profiling using array comparative genomic hybridization define distinct subtypes of diffuse large B-cell lymphoma: a review of the literature.
    Tirado CA; Chen W; García R; Kohlman KA; Rao N
    J Hematol Oncol; 2012 Sep; 5():54. PubMed ID: 22967872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent numerical aberrations of JAK2 and deregulation of the JAK2-STAT cascade in lymphomas.
    Meier C; Hoeller S; Bourgau C; Hirschmann P; Schwaller J; Went P; Pileri SA; Reiter A; Dirnhofer S; Tzankov A
    Mod Pathol; 2009 Mar; 22(3):476-87. PubMed ID: 19136931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical impact of recurrently mutated genes on lymphoma diagnostics: state-of-the-art and beyond.
    Rosenquist R; Rosenwald A; Du MQ; Gaidano G; Groenen P; Wotherspoon A; Ghia P; Gaulard P; Campo E; Stamatopoulos K;
    Haematologica; 2016 Sep; 101(9):1002-9. PubMed ID: 27582569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A genetic profiling guideline to support diagnosis and clinical management of lymphomas.
    Sánchez-Beato M; Méndez M; Guirado M; Pedrosa L; Sequero S; Yanguas-Casás N; de la Cruz-Merino L; Gálvez L; Llanos M; García JF; Provencio M
    Clin Transl Oncol; 2024 May; 26(5):1043-1062. PubMed ID: 37672206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenetics in the management of lymphomas and lymphoproliferative disorders in adults and children: an update by the Groupe francophone de cytogénétique hématologique (GFCH).
    Lefebvre C; Callet-Bauchu E; Chapiro E; Nadal N; Penther D; Poirel HA
    Ann Biol Clin (Paris); 2016 Oct; 74(5):568-587. PubMed ID: 27707672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytogenomics of B-cell non-Hodgkin lymphomas: The "old" meets the "new".
    Grau M; López C; Martín-Subero JI; Beà S
    Best Pract Res Clin Haematol; 2023 Dec; 36(4):101513. PubMed ID: 38092483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal Nk/T-cell lymphoma, nasal type.
    Nakashima Y; Tagawa H; Suzuki R; Karnan S; Karube K; Ohshima K; Muta K; Nawata H; Morishima Y; Nakamura S; Seto M
    Genes Chromosomes Cancer; 2005 Nov; 44(3):247-55. PubMed ID: 16049916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative cytogenetic and cytologic study in malignant lymphomas.
    Răileanu-Motoiu I; Gociu M; Leahu S; Berceanu S
    Med Interne; 1976; 14(2):115-20. PubMed ID: 1024250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.